<?xml version="1.0" encoding="UTF-8"?>
<p>The Viral Haemorrhagic Fever (VHF) Surveillance and Laboratory Program located at the Uganda Virus Research Institute (UVRI) in Entebbe Uganda, received a blood sample from an individual suspected to be infected with a VHF virus from Kaproron Health Centre IV (Kween District) on 16
 <sup>th</sup> October 2017. The sample was submitted by Kween District health team after suspecting a VHF following the death of two people in one family with similar clinical symptoms. The serum sample was tested on the day of arrival by RT-PCR for Crimean-Congo haemorrhagic fever virus, Ebolaviruses (
 <italic>Bundibugyo ebolavirus</italic>, 
 <italic>Sudan ebolavirus and Zaire ebolavirus)</italic>, Marburg virus and Rift Valley Fever virus and found to be preliminarily positive for Marburg virus. The sample was re-tested and confirmed positive on 17
 <sup>th</sup> October 2017. The Uganda Ministry of Health (MoH) National Task Force (NTF) was activated on 18
 <sup>th</sup> October 2017 at the Public Health Emergency Operations Centre (PHEOC). A multi-sectoral and multidisciplinary National Rapid Response Team (NRRT) was established and deployed to Kween and Kapchorwa districts on 18
 <sup>th</sup> October 2017. The outbreak was officially declared by the Ministry of Health (MOH) on 19
 <sup>th</sup> October 2017. District Rapid Response Teams (DRRTs) were deployed within the affected Districts on the same day. This multi-sectoral team worked to conduct a rapid outbreak investigation and assessment, and initiated intervention measures. We present results from the epidemiological and laboratory investigations of the MVD outbreak and propose recommendations for future filovirus outbreaks.
</p>
